I hope I am wrong, but I suspect that it is going to take longer than most think before we get a significant run-up. As Bucc and Kelt say, there's an opportunity to buy in dead ahead.

If this goes like biotechs often do, there very well may be an attempt to run stops and take this down big, maybe into the .70's again. Don't be one of the people who gets stopped out and then feels like a sucker when it runs.